Body-wide inflammation may fuel Parkinson’s disease

The brain is well protected: the blood-brain barrier keeps most harmful substances out. Yet that barrier may not prevent inflammation from the body from reaching the brain. Earlier work had shown that microglia, the brain’s own immune cells, become activated with aging. What was less clear is how systemic inflammation from the body fans those flames.

A new study discussed on Lifespan.io proposes that aging or Parkinson’s-related genetic mutations generate inflammation in tissues outside the brain. That inflammation then spreads via extracellular vesicles, tiny packets released by cells into the bloodstream that carry molecular signals. These vesicles may then transport inflammatory signals to the brain and contribute to disease progression.

A bridge between body and brain

Inflammaging, the smoldering, chronic low-grade inflammation that accumulates with age, plays a central role in this hypothesis. The idea is that genetic predisposition to Parkinson’s may not immediately damage the brain directly, but first generates inflammation in peripheral tissues. That inflammation is then relayed via the bloodstream to the brain.

Extracellular vesicles are the proposed messengers in this process. They are small enough to cross or bypass the blood-brain barrier. Whether this is the actual route, and to what extent, has not yet been definitively established. This remains an early mechanistic proposal that requires further investigation.

Treatment may need to start outside the brain

If peripheral inflammation is indeed an early driver of Parkinson’s, that has implications for treatment strategy. Interventions targeting body-wide inflammation early in the disease course could be more effective than approaches focused exclusively on the brain. That is an interesting conceptual shift, but given how early this research is, that conclusion should be drawn with care.

Read the original article